Literature DB >> 22358078

Pharmacological activity of salvinorin A, the major component of Salvia divinorum.

Joanna Listos1, Alicja Merska, Sylwia Fidecka.   

Abstract

The hallucinogenic plant Salvia divinorum (i.e., "magic mint") is a member of the Sage family that has been historically used for divination and shamanism by the Mazatecs. Today, S. divinorum has become increasingly popular as a recreational drug for its hallucinogenic effects. The non-nitrogenous diterpene, salvinorin A, the major active component of S. divinorum, is responsible for the hallucinogenic effect of this plant. Here, we described the behavioral effects of salvinorin A in animals including the addictive, antinociception and antidepressant properties of the drug. The present paper also demonstrates the not well recognized (or unclear) mechanisms of action of salvinorin A. The last part of the paper presents information about the legal status of S. divinorum and its derivatives. Taking into account the increasing popularity and consumption of salvinorin A and S. divinorum today, it is important to collect all data on the pharmacological profile of this plant and its products.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22358078     DOI: 10.1016/s1734-1140(11)70694-6

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  9 in total

1.  Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats.

Authors:  Matthew L Lazenka; Megan J Moerke; E Andrew Townsend; Kevin B Freeman; F Ivy Carroll; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2017-10-24       Impact factor: 4.530

2.  Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.

Authors:  Alaina M Jaster; Harrison Elder; Samuel A Marsh; Mario de la Fuente Revenga; S Stevens Negus; Javier González-Maeso
Journal:  Psychopharmacology (Berl)       Date:  2022-03-02       Impact factor: 4.530

Review 3.  Kappa Opioids, Salvinorin A and Major Depressive Disorder.

Authors:  George T Taylor; Francesca Manzella
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 4.  Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects.

Authors:  Andreia Machado Brito-da-Costa; Diana Dias-da-Silva; Nelson G M Gomes; Ricardo Jorge Dinis-Oliveira; Áurea Madureira-Carvalho
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-03

5.  Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders.

Authors:  Joseph Cichon; Renyu Liu; Hoang V Le
Journal:  Transl Perioper Pain Med       Date:  2022-06-29

Review 6.  Natural Products for the Treatment of Pain: Chemistry and Pharmacology of Salvinorin A, Mitragynine, and Collybolide.

Authors:  Soumen Chakraborty; Susruta Majumdar
Journal:  Biochemistry       Date:  2020-09-22       Impact factor: 3.162

7.  The claustrum's proposed role in consciousness is supported by the effect and target localization of Salvia divinorum.

Authors:  Klaus M Stiefel; Alistair Merrifield; Alex O Holcombe
Journal:  Front Integr Neurosci       Date:  2014-02-26

8.  Salvinorin A Does Not Affect Seizure Threshold in Mice.

Authors:  Katarzyna Socała; Urszula Doboszewska; Piotr Wlaź
Journal:  Molecules       Date:  2020-03-07       Impact factor: 4.411

9.  Quantitative determination of salvinorin A, a natural hallucinogen with abuse liability, in Internet-available Salvia divinorum and endemic species of Salvia in Taiwan.

Authors:  Po-Xiang Lin; Jih-Heng Li; Su-Hwei Chen; Hsien-Chang Chang; Rebecca McKetin
Journal:  J Food Drug Anal       Date:  2014-02-16       Impact factor: 6.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.